AXIO | Proficiency Testing schemes 2026
Quantity of Matrix
Rounds per Year
Sample Code Matrix
Analytes
PT-QZ-01+02 Blood
2 x 10ml
Sample 1: Participants will be asked to identify up to 4 drugs relevant to forensic toxicology; Sample 2: Quantification of a known drug (full identity or generic classification)
4
PT-QZ-03
Blood
2 x 10ml
Sample 3A: Morphine, Methadone, Amphetamine Diazepam. Sample 3B: Citalopram, Codeine, Amitriptyline, Tramadol
2
PT-QZ-04
Blood
10ml
Quantification of alcohol and fluoride in a blood sample 2 Interpretation of a case study (with analytical data, and a scenario or witness statement) to determine the potential blood alcohol level at a given time 2 Participants are asked to quantify/identify a range of new psychoactive substances; (NPS). Two substances are named and are for quantification and a further two substances are not named and are to be identified by screening (quantification results may also be included) 2
PT-QZ-05
Paper exercise
-
PT-QZ-06
Blood
10ml
PT-QZ-07
Blood
10ml
Participants are asked to screen for synthetic cannabinoids and identify one of the most common synthetic cannabinoids Participants are asked to identify up to 4 drugs or metabolites relevant to forensic toxicology
2
PT-QZ-08
Urine
10ml
2
PT-QZ-09
Urine
10ml
A urine sample specifically for New Psychoactive Substance screening and may include synthetic cannabinoids. Up to two substances may be present. No interpretation is required 2 Sample 10A: Oxycodone, Pregabalin, MDMA and Mirtazapine Sample 10B: Loratidine, Gabapentin, Quetiapine and Valproate 2
PT-QZ-10
Blood
2 x 10ml
Download Application Form Download Scheme Description
lgcstandards.com/AXIO 121
Made with FlippingBook - professional solution for displaying marketing and sales documents online